Analyst Ratings for West Pharmaceutical (WST)
WST Rating Summary
WST Price Target Summary
- Highest: $447.00 (BNP Paribas Exane)
- Lowest: $311.00 (Rothschild Redburn)
- Average: $385.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$385.30 (+15.9%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
Avg. $ Target:
$385.30 (+15.9%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | UBS | Douglas Schenkel | New Coverage | Buy (N/A) |
415.00 (N/A) |
337.75 (332.32) |
-1.61% | Details |
| 7/13/2026 | BNP Paribas Exane | N/A | New Coverage | Outperform (N/A) |
447.00 (N/A) |
353.71 (332.32) |
-6.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
